Login / Signup

Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real-World Outcomes in Psoriasis Treatment.

Sarah E ThomasMarieke M B SeygerJosje E MangnusMarisol E OteroAntoni H GostynskiMarcellus D NjooPaul M OssenkoppeleInge M HaeckJudith H J Hendricksen-RoelofzenJohn E M KörverSharon R P DodemontRon A TupkerMaartje A M BerendsLizelotte M J T Weppner-ParrenRomy R M C KeijsersAnnet M OostveenBas PetersRoland MommersMartijn B A van DoornMilan TjioeWendelien R VeldkampAstrid L A KuijpersMarloes M KleinpenningElke M G J de JongJuul M P A van den Reek
Published in: American journal of clinical dermatology (2024)
Keyphrases
  • type diabetes
  • metabolic syndrome
  • atopic dermatitis